Triple, dual and single incretin receptor agonists alongside the wider metabolic set — NNMT inhibitors, mitochondrial uncouplers and fatty-acid transport compounds.
Join the Peps Depot list for high-demand restock alerts, subscriber-only offers, release updates and priority access — plus The Friday Brief, our weekly deep-dive on what actually moved in peptide research that week. New compounds, new data, regulatory shifts. Nowhere else.